ADA 2019 In Review

The biggest diabetes conference of the year — American Diabetes Association’s 79th Annual Scientific Sessions is over, and Beyond Type 2’s editorial staff was reporting live from the conference. Here are the highlights, lowlights, insights, and biggest takeaways from ADA 2019.

Long-Term Effects of Dulaglutide on People With T2D: Results from the REWIND Trial

Researchers reveal the longterm effects of GLP-1 drug on cardiovascular disease in people with Type 2 diabetes.

Introducing Francine Kaufman: Newest Member of Science Advisory Council

Meet Francine Kaufman M.D., the newest member of the Beyond Type 1 Science Advisory Council! Dr. Kaufman recently spoke with Beyond Type 1 about her history of treating diabetes, her work abroad, the global diabetes landscape, and the future of T1D.

Symptoms of Type 2 Diabetes

Type 2 diabetes is a chronic disease that affects the way the body metabolizes glucose. Those with T2D are finding that their body either resists the effects of the insulin they are producing or that they merely do not produce enough insulin to maintain proper levels of glucose.